Balentine LLC’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,535
Closed -$206K 627
2022
Q4
$206K Buy
+2,535
New +$204K 0.01% 537
2022
Q3
Sell
-4,282
Closed -$384K 633
2022
Q2
$384K Buy
4,282
+1,795
+72% +$186K 0.01% 374
2022
Q1
$279K Buy
+2,487
New +$291K 0.01% 447
2020
Q3
Sell
-209
Closed -$15K 367
2020
Q2
$15K Buy
209
+193
+1,206% +$12.2K ﹤0.01% 450
2020
Q1
$1K Buy
+16
New +$1.03K ﹤0.01% 612
2019
Q4
Sell
-1,422
Closed -$105K 645
2019
Q3
$105K Buy
1,422
+1,400
+6,364% +$100K 0.01% 96
2019
Q2
$2K Sell
22
-1,396
-98% -$106K ﹤0.01% 621
2019
Q1
$108K Hold
1,418
0.01% 91
2018
Q4
$104K Buy
+1,418
New +$113K 0.01% 83
2018
Q1
Sell
-42
Closed -$4K 201
2017
Q4
$4K Hold
42
﹤0.01% 532
2017
Q3
$4K Hold
42
﹤0.01% 531
2017
Q2
$4K Hold
42
﹤0.01% 507
2017
Q1
$3K Buy
+42
New +$3.3K ﹤0.01% 503
2015
Q4
Sell
-817
Closed -$57.2K 426
2015
Q3
$53K Buy
+817
New +$60.3K 0.01% 163

Other funds holding EMN

Balentine LLC's EMN Position: Q1 2023 in Review

Balentine LLC sold out of Eastman Chemical (EMN) in Q1 2023, closing a stake of 2,535 shares — an estimated $206K sold.

Balentine LLC first reported a position in EMN in Q3 2015 and held it in 14 quarters. The position peaked at $384K in Q2 2022. 694 funds tracked by Wall St. Rank hold EMN as of Q1 2023.

  • Balentine LLC reported no remaining Eastman Chemical position as of Q1 2023 after selling out during the quarter.
  • Balentine LLC sold 2,535 Eastman Chemical shares in Q1 2023, an estimated $206K.
  • Balentine LLC first reported a position in Eastman Chemical in Q3 2015 and held it in 14 quarters.
  • Balentine LLC's Eastman Chemical position peaked at $384K in Q2 2022.
  • 694 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2023.

Based on Balentine LLC's 13F filing for Q1 2023, filed 11 May 2023.